Taimed Biologics Inc.
Clinical trials sponsored by Taimed Biologics Inc., explained in plain language.
-
HIV patients may soon get shorter, simpler injections
Disease control CompletedThis study tested whether Trogarzo, an HIV medication, can be given safely as a quick IV push (over 30 seconds) or as a muscle injection instead of a longer IV drip. It involved 43 people with stable HIV who were already taking Trogarzo, plus some healthy volunteers. The goal was…
Phase: PHASE3 • Sponsor: TaiMed Biologics Inc. • Aim: Disease control
Last updated May 26, 2026 06:19 UTC
-
HIV patients may ditch daily pills for Twice-Yearly antibody shots
Disease control CompletedThis study tested a combination of two lab-made antibodies (TMB-365 and TMB-380) in 51 adults with HIV whose virus was already well-controlled by daily oral medication. The goal was to see if these antibodies, given as intravenous infusions every 8 weeks, could safely keep the vi…
Phase: PHASE1, PHASE2 • Sponsor: TaiMed Biologics Inc. • Aim: Disease control
Last updated May 04, 2026 16:23 UTC